“…Western Canadian Conference on Computing Education 2011…”

“…CADTH Canadian Drug Expert Committee final recommendation Tiotropium/Olodaterol…”

“…CADTH Canadian Drug Expert Committee final recommendation Emtricitabine / tenofovir alafenamide…”

Materias: “…Peace-building, Canadian Afghanistan Congresses…”
Enlace del recurso

Materias: “…Children's stories, Canadian.…”
Click para texto completo desde fuera UPSA
Click para texto completo desde UPSA

Materias: “…Border security Canadian-American Border Region…”

“…The analysis was based on an individual patient simulation model estimating long-term health care costs and quality-adjusted life-years (QALYs) over a lifetime horizon (40 years), from the perspective of the Canadian public health care payer. The manufacturer reported that ticagrelor + ASA was associated with greater QALYs and higher costs than ASA alone, with an estimated incremental cost per QALY gained of 59,724 dollar…”

“…Riociguat was previously reviewed for this indication (at the same submitted price) and received a "list with conditions" recommendation by the CADTH Canadian Drug Expert Committee (CDEC) in July 2014, one of which was the requirement of a substantial reduction in price…”

“…Omalizumab was originally submitted to the CADTH Common Drug Review (CDR) for this indication in April 2005; however, a final recommendation by the Canadian Expert Drug Advisory Committee (CEDAC) was not issued since a request for reconsideration from the manufacturer was deemed to include new information requiring resubmission. …”

“…The analysis was based on a Markov state-transition model using a 45-year time horizon and undertaken from the perspective of the Canadian publicly funded health care system. The manufacturer reported that, compared with treatment with SoC, ixekizumab has an incremental cost-utility ratio (ICUR) of 113,023 per quality-adjusted life-year (QALY). …”